Intralesional Triamcinolone Acetonide in the Treatment of Traction Alopecia

The study evaluated the effectiveness and safety of intralesional triamcinolone acetonide injections (ILK) in treating traction alopecia (TA) in 6 African American women. The patients received ILK at a concentration of 5 mg/mL in areas of low hair density along the frontotemporal hairline at 6 to 8-week intervals for 3 visits. All subjects showed visible increases in hair density after the first or second treatment, with no severe adverse effects reported. Common side effects included pain and transient atrophy at the injection site, which did not necessitate stopping treatment. The study concluded that ILK is an effective and safe treatment for TA, especially in early to mid-stages, and emphasized the importance of patient education to prevent TA by avoiding hairstyles that exert tension on the hairline.